I read the report this morning. Interesting, If Iclusig is allowed to re-enter the US market, then maybe such a buyout would not be necessary. However if the FDA drags their feet, then it would be a probable..IMO
If true, that would value ARIA at about 8 dollars per share. (i.e. 2 B divided by the float of about 250M).
So, if that is indeed true, it appears that 8 bucks would be a ceiling for this stock. I don't believe such a rumor, in any event. GLTA.
Headlines: Ready, Willing And Able_Pfizer (PFE) Increases Offer For Acquisition Of Ariad Pharmaceuticals (ARIA) Following Positive News On Iclusig From European Medicines Agency Ventures Sierra World Equity Review. Shares of Ariad Pharmaceuticals rose over 6% today on what Sierra’s leads believe is an increased buyout offer placed on the table by big pharma Pfizer. Sierra and her team are monitoring any potential meeting activity at Pfizer HQ in New York City this weekend and will be providing instant updates as needed. Sierra will also be holding a live Skype conference call on Sunday afternoon with her team who are tracking the Pfizer-Ariad Pharmaceuticals potential buyout. For those interested in joining the Skype conference call the time and contact connection details will be published on Sierra’s site Sunday afternoon.